Pomalyst and Immunoglobulins decreased - a phase IV clinical study of FDA data
Summary:
Immunoglobulins decreased is reported as a side effect among people who take Pomalyst (pomalidomide), especially for people who are male, 60+ old, also take Darzalex, and have Multiple myeloma.
The phase IV clinical study analyzes which people have Immunoglobulins decreased when taking Pomalyst. It is created by eHealthMe based on reports of 80,394 people who have side effects when taking Pomalyst from the FDA, and is updated regularly.
What is Pomalyst?
Pomalyst has active ingredients of pomalidomide. eHealthMe is studying from 80,400 Pomalyst users. Check the latest studies of Pomalyst.
What is Immunoglobulins decreased?
Immunoglobulins decreased is found to be associated with 267 drugs and 259 conditions by eHealthMe. Check the latest studies of Immunoglobulins decreased.
80,394 people reported to have side effects when taking Pomalyst.
Among them, 15 people (0.02%) have Immunoglobulins decreased.

Among these 15 people:
What is the gender of people who have Immunoglobulins decreased when taking Pomalyst? *
- female: 40 %
- male: 60 %
What is the age of people who have Immunoglobulins decreased when taking Pomalyst? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 14.29 %
- 60+: 85.71 %
What are other drugs people take besides Pomalyst? *
- Calcium: 4 people, 26.67%
- Darzalex: 4 people, 26.67%
- Acyclovir: 3 people, 20.00%
- Dexamethasone: 3 people, 20.00%
- Vitamin B12: 2 people, 13.33%
- Eliquis: 2 people, 13.33%
- Gabapentin: 2 people, 13.33%
- Magnesium: 2 people, 13.33%
- Vitamin B6: 1 person, 6.67%
- Fluticasone Propionate: 1 person, 6.67%
What are other side effects people have besides Immunoglobulins decreased? *
- White Blood Cell Count Decreased: 3 people, 20.00%
- Muscle Spasms (muscle contraction): 3 people, 20.00%
- Hypoaesthesia (reduced sense of touch or sensation): 3 people, 20.00%
- Constipation: 2 people, 13.33%
- Fatigue (feeling of tiredness): 2 people, 13.33%
- Nasopharyngitis (inflammation of the nasopharynx): 2 people, 13.33%
- Insomnia (sleeplessness): 1 person, 6.67%
- Aggression: 1 person, 6.67%
- Anaemia (lack of blood): 1 person, 6.67%
- Back Pain: 1 person, 6.67%
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 15 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Pomalyst and have Immunoglobulins decreased?
- Check whether Immunoglobulins decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Pomalyst:
- Pomalyst (80,400 reports)
Immunoglobulins decreased treatments and more:
- Immunoglobulins decreased (1,811 reports)
How severe was Immunoglobulins decreased and when was it recovered:
Expand to all the drugs that have ingredients of pomalidomide:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pomalyst:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Immunoglobulins decreased:
- Immunoglobulins decreased (267 drugs)
Browse all the conditions that are associated with Immunoglobulins decreased:
- Immunoglobulins decreased (259 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on pomalidomide (the active ingredients of Pomalyst) and Pomalyst (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Imodium cause Diplopia? - 3 seconds ago
- Could Tylenol W/ Codeine cause Intestinal Obstruction? - 5 seconds ago
- Fentanyl and Hctz drug interactions for men aged 60+ - 6 seconds ago
- Drug interactions of Mobic and Magnesium Oxide - 6 seconds ago
- Could Stelara cause Cholecystitis Infective? - 8 seconds ago
- Keppra and Cellcept drug interactions for girls aged 10-19 - 12 seconds ago
- Drug interactions of Hycodan and Demerol - 23 seconds ago
- Taltz and Protopic drug interactions for women aged 50-59 - 26 seconds ago
- Dizziness in Nebivolol Hydrochloride, how severe and when it was recovered? - 27 seconds ago
- Could Furosemide cause Stroke? - 59 seconds ago